Jewel AF ICD Atrial Fib Detection Sensitivity/Specificity Tops 99%
This article was originally published in The Gray Sheet
Executive Summary
Medtronic's Jewel AF dual-chamber implantable cardioverter defibrillator (ICD) continuously detects sustained atrial fibrillation (AF) and atrial flutter (AFl) with over 99% sensitivity/specificity and can be programmed for long duration AF without the risk of underdetection, Charles Swerdlow, MD, Cedars-Sinai Medical Center, Los Angeles, reported Nov. 8 at the American Heart Association's annual scientific sessions in Atlanta.
You may also be interested in...
Medtronic Jewel AF ICD Approvable With Conditions, FDA Panel Says
Medtronic expects FDA approval of its Jewel AF dual chamber implantable cardioverter defibrillator by the end of the year following a unanimous (4-0) approval with conditions recommendation June 24 from the agency's Circulatory System Devices Panel.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.